Carbohydrate-Protein Supplementation During Endurance Running
NCT ID: NCT00972387
Last Updated: 2018-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2009-08-31
2010-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein Supplementation and Endurance Exercise Adaptations
NCT03462381
Breakfast Consumption and Energy Balance in Active Adult Males
NCT04862208
Effect of Carbohydrate-protein Co-ingestion on Short-term Recovery
NCT04859491
Protein Before Night Sleep to Improve Recovery and Performance in Runners
NCT03147833
Effect of Nutrition on Muscle Protein Synthesis
NCT00604929
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Order 1
Supplement order for each time trial run, 1-4 respectively: CHO, CHO-P, CHO-CHO, PLA
CHO, CHO-P, CHO-CHO, PLA
The CHO supplement will be administered during trial 1. The CHO-P will be administered during trial 2. The CHO-CHO supplement will be administered during trial 3. The PLA supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
Order 2
Supplement order for each time trial run, 1-4 respectively: CHO-P, CHO-CHO, PLA, CHO
CHO-P, CHO-CHO, PLA, CHO
The CHO-P supplement will be administered during trial 1. The CHO-CHO will be administered during trial 2. The PLA supplement will be administered during trial 3. The CHO supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
Order 3
Supplement order for each time trial run, 1-4 respectively: CHO-CHO, PLA, CHO, CHO-P
CHO-CHO, PLA, CHO, CHO-P
The CHO-CHO supplement will be administered during trial 1. The PLA will be administered during trial 2. The CHO supplement will be administered during trial 3. The CHO-P supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
Order 4
Supplement order for each time trial run, 1-4 respectively: PLA, CHO, CHO-P, CHO-CHO
PLA, CHO, CHO-P, CHO-CHO
The PLA supplement will be administered during trial 1. The CHO will be administered during trial 2. The CHO-P supplement will be administered during trial 3. The CHO-CHO supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CHO, CHO-P, CHO-CHO, PLA
The CHO supplement will be administered during trial 1. The CHO-P will be administered during trial 2. The CHO-CHO supplement will be administered during trial 3. The PLA supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
CHO-P, CHO-CHO, PLA, CHO
The CHO-P supplement will be administered during trial 1. The CHO-CHO will be administered during trial 2. The PLA supplement will be administered during trial 3. The CHO supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
CHO-CHO, PLA, CHO, CHO-P
The CHO-CHO supplement will be administered during trial 1. The PLA will be administered during trial 2. The CHO supplement will be administered during trial 3. The CHO-P supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
PLA, CHO, CHO-P, CHO-CHO
The PLA supplement will be administered during trial 1. The CHO will be administered during trial 2. The CHO-P supplement will be administered during trial 3. The CHO-CHO supplement will be administered during trial 4. This is the order of supplement administration for subjects randomly assigned to this order group.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI in the healthy range, 18.5-24.9
* Run 45-90+ minutes at least 4 days per week
* Engage in running this frequency and duration for at least 4 weeks prior to the phone screen
* Engage in a run consisting ≥10 miles in length for at least 2-4 occasions per month for at least 2 months prior to the phone screen
* No previous history of heart conditions
* No shortness of breath or chest pain experienced during running or daily activities
* No bone or joint problems experienced during running or daily activities
Exclusion Criteria
* Females are excluded from this study in order to prevent any potential factors associated with the female athlete triad and endurance performance outcomes.
* BMI below 18.5 or greater than 24.9
* Does not meet all other criteria listed (#3-6)
* Allergies to products containing milk, soy, or aspartame
* Severe allergies to eggs, wheat, tree nuts, fish, crustaceans, shellfish products (Accelerade, the CHO-P supplement, is made in a facility that processed these products)
* Refusal to consume any of the supplements, and/or extreme dislike of the supplements
* Refusal to complete the specified distance of the time trials
18 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of Tennessee, Knoxville
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hollie Raynor
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hollie A Raynor, PhD
Role: STUDY_CHAIR
University of Tennessee, Knoxville
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Health Physical Education and Recreation Building
Knoxville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
University of TN IRB 7959-B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.